|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6400 SEK | +0.63% |
|
+0.95% | +6.67% |
| 07-27 | AcuCort Receives Renewed FDA Small Business Waiver Ahead of Planned NDA Submission | CI |
| 07-27 | AcuCort Renews US FDA Small Business Waiver for New Drug Applications | MT |
| Market Cap | 150M 15.43M 13.56M 12.65M 11.61M 21.74M 1.48B 22.27M 58.68M 731M 57.92M 56.66M 2.53B | P/E 2024 |
-3.61x | P/E 2025 | -5x |
|---|---|---|---|---|---|
| Enterprise Value | 123M 12.65M 11.12M 10.38M 9.52M 17.82M 1.21B 18.26M 48.11M 600M 47.49M 46.46M 2.07B | EV / Sales 2024 |
11.3x | EV / Sales 2025 | 17x |
| Free-Float |
36.58% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.63% | ||
| 1 week | +0.95% | ||
| Current month | +5.26% | ||
| 1 month | +7.38% | ||
| 3 months | -9.86% | ||
| 6 months | -21.28% | ||
| Current year | +6.67% |
| 1 week | 0.58 |  | 0.65 |
| 1 month | 0.53 | | 0.67 |
| Current year | 0.4 | | 0.95 |
| 1 year | 0.4 | | 0.95 |
| 3 years | 0.33 | | 1.26 |
| 5 years | 0.33 | | 4.98 |
| 10 years | 0.33 | | 9.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 09/08/2020 | |
| Corporate Officer/Principal | 53 | 14/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 68 | 08/02/2017 | |
| Chairman | 63 | 01/01/2018 | |
Göran Tornling
BRD | Director/Board Member | 79 | 01/01/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.63% | +0.95% | -5.88% | -44.83% | 15.43M | |
| -1.80% | +4.75% | -21.83% | -30.23% | 16.27B | |
| -1.67% | +2.92% | -28.83% | -36.05% | 7.4B | |
| -2.01% | +7.98% | -15.26% | -4.82% | 6.46B | |
| +1.02% | +4.32% | -4.82% | -29.25% | 4.06B | |
| +1.11% | +5.05% | -22.22% | -45.60% | 3.28B | |
| +0.74% | +1.17% | +9.08% | -32.36% | 3.19B | |
| 0.00% | -1.35% | -41.74% | -23.50% | 3.02B | |
| +2.65% | +7.10% | -9.89% | +5.73% | 2.72B | |
| -2.08% | +3.07% | +101.62% | - | 2.6B | |
| Average | -0.14% | +4.67% | -3.98% | -26.77% | 4.9B | |
| Weighted average by Cap. | -0.87% | +5.35% | -12.64% | -26.23% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7.72M 793K 697K 651K 597K 1.12M 76M 1.15M 3.02M 37.61M 2.98M 2.91M 130M | 6.68M 687K 604K 564K 517K 968K 65.82M 992K 2.61M 32.57M 2.58M 2.52M 113M |
| Net income | -17.4M -1.79M -1.57M -1.47M -1.35M -2.52M -171M -2.58M -6.8M -84.79M -6.72M -6.57M -293M | -26.19M -2.69M -2.37M -2.21M -2.03M -3.79M -258M -3.89M -10.24M -128M -10.11M -9.89M -441M |
| Net Debt | -2.77M -285K -250K -234K -215K -402K -27.3M -411K -1.08M -13.51M -1.07M -1.05M -46.7M | -27.01M -2.78M -2.44M -2.28M -2.09M -3.91M -266M -4.01M -10.56M -132M -10.43M -10.2M -455M |
Employees
5
Sector
Drug Retailers
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/07/26 | SEK 0.6400 | +0.63% | 163,874 |
| 28/07/26 | SEK 0.6360 | +0.95% | 39,443 |
| 27/07/26 | SEK 0.6300 | 0.00% | 145,397 |
| 24/07/26 | SEK 0.6300 | +4.30% | 303,208 |
| 23/07/26 | SEK 0.6040 | -4.73% | 75,130 |
- Stock Market
- Stocks
- ACUC Stock
Select your edition
All financial news and data tailored to specific country editions
